Monopar Therapeutics Inc. buy Midas
Start price
24.10.20
/
50%
€4.00
Target price
04.11.21
-
Performance (%)
37.50%
End price
26.01.21
€5.50
Summary
This prediction ended on 26.01.21 with a price of €5.50. The BUY prediction by Midas for Monopar Therapeutics Inc. saw massive gains of 37.50%. Midas has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Monopar Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% | 68.786% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% | 100.066% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% | 43.024% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% | 63.222% |
Comments by Midas for this prediction
In the thread Monopar Therapeutics Inc. diskutieren
Buy Monopar Therapeutics Inc.